日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiative

局部结肠癌患者辅助治疗随机试验中事件发生时间终点定义指南:DATECAN 计划的结果

Cohen, Romain; Vernerey, Dewi; Bellera, Carine; Meurisse, Aurélia; Henriques, Julie; Paoletti, Xavier; Rousseau, Benoît; Alberts, Steven; Aparicio, Thomas; Boukovinas, Ioannis; Gill, Sharlene; Goldberg, Richard M; Grothey, Axel; Hamaguchi, Tetsuya; Iveson, Timothy; Kerr, Rachel; Labianca, Roberto; Lonardi, Sara; Meyerhardt, Jeffrey; Paul, James; Punt, Cornelis J A; Saltz, Leonard; Saunders, Marck P; Schmoll, Hans-Joachim; Shah, Manish; Sobrero, Alberto; Souglakos, Ioannis; Taieb, Julien; Takashima, Atsuo; Wagner, Anna Dorothea; Ychou, Marc; Bonnetain, Franck; Gourgou, Sophie; Yoshino, Takayuki; Yothers, Greg; de Gramont, Aimery; Shi, Qian; André, Thierry

Use of AFLP and RAPD molecular genetic markers and cytogenetic analysis to explore relationships among taxa of the Patagonian Bromus setifolius complex

利用AFLP和RAPD分子遗传标记以及细胞遗传学分析,探讨巴塔哥尼亚雀麦复合群各分类单元之间的关系。

García, Ana M; Schrauf, Gustavo E; González, Graciela; Poggio, Lidia; Naranjo, Carlos A; Dupal, Marck P; Spangenberg, Germán C; Forster, John W

NF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation

炎性乳腺癌中的 NF-kappaB 激活与雌激素受体下调有关,继发于 EGFR 和/或 ErbB2 过度表达和 MAPK 过度活化

S J Van Laere, I Van der Auwera, G G Van den Eynden, P van Dam, E A Van Marck, P B Vermeulen, L Y Dirix

Building safer systems by ecological design: using restoration science to develop a medication safety intervention

通过生态设计构建更安全的系统:利用修复科学开发药物安全干预措施

Marck, P B; Kwan, J A; Preville, B; Reynes, M; Morgan-Eckley, W; Versluys, R; Chivers, L; O'Brien, B; Van der Zalm, J; Swankhuizen, M; Majumdar, S R